Botulinum toxin in upper limb spasticity after acquired brain injury - A randomized trial comparing dilution techniques

被引:69
作者
Francisco, GE
Boake, C
Vaughn, A
机构
[1] Univ Texas, Sch Med, Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA
[2] Inst Rehabil & Res, Houston, TX USA
关键词
botulinum toxin; human; muscle spasticity; drug therapy; clinical trial; randomized controlled trial;
D O I
10.1097/00002060-200205000-00007
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To compare the efficacy of two different volume preparations of the same dose of botulinum toxin-A in relieving spasticity in wrist and finger flexors secondary to acquired brain injury. Design: Thirteen adult patients who had modified Ashworth scale scores of 3 for both wrist and finger flexors were included in this randomized, controlled trial. Wrist and finger flexors were each injected. Blinded modified Ashworth scale ratings of wrist and finger flexor spasticity were measured. Results: Spasticity in both muscles decreased significantly in both treatment groups. However, the high-volume and low-volume groups did not differ significantly in spasticity reduction. Conclusions: Because this preliminary study found no difference in spasticity reduction between high- and low-volume preparations of a 60-unit dose of botulinum toxin-A, a larger-sample study seems warranted to compare the efficacy of high-volume and low-volume preparations.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 26 条
  • [1] [Anonymous], 1997, MUSCLE NERVE, V6, pS1
  • [2] ASHWORTH B, 1964, PRACTITIONER, V192, P540
  • [3] Use of botulinum toxin in stroke patients with severe upper limb spasticity
    Bhakta, BB
    Cozens, JA
    Bamford, JM
    Chamberlain, MA
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (01) : 30 - 35
  • [4] INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY
    BOHANNON, RW
    SMITH, MB
    [J]. PHYSICAL THERAPY, 1987, 67 (02): : 206 - 207
  • [5] BORGSTEIN J, 1993, AM J PHYS MED REHAB, V72, P364
  • [6] HISTOLOGIC ASSESSMENT OF DOSE-RELATED DIFFUSION AND MUSCLE-FIBER RESPONSE AFTER THERAPEUTIC BOTULINUM-A TOXIN INJECTIONS
    BORODIC, GE
    FERRANTE, R
    PEARCE, LB
    SMITH, K
    [J]. MOVEMENT DISORDERS, 1994, 9 (01) : 31 - 39
  • [7] A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
    Burbaud, P
    Wiart, L
    Dubos, JL
    Gaujard, E
    Debelleix, X
    Joseph, PA
    Mazaux, JM
    Bioulac, B
    Barat, M
    Lagueny, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) : 265 - 269
  • [8] Chutorian A, 1994, INT PEDIAT S1, V9, P35
  • [9] Cosgrove AP, 1992, J BONE JOINT SURG S2, V74, P135
  • [10] The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans
    Eleopra, R
    Tugnoli, V
    DeGrandis, D
    [J]. MOVEMENT DISORDERS, 1997, 12 (01) : 89 - 94